Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: A historical cohort study

Metabolism: Clinical and Experimental

Volumn 60, Issue 10, 2011, Pages 1379-1385

  Buchs, Andreas E ^a,b   Silverman, Barbara G ^c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MACCABI HEALTHCARE SERVICES   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HUMAN INSULIN; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; METFORMIN; SULFONYLUREA;

ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; COHORT ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL RECORD; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; ISRAEL; MALE; MIDDLE AGED; NEOPLASMS; SAMPLE SIZE; YOUNG ADULT;

EID: 80052965511     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.05.002     Document Type: Article

References (32)

1. X. Ren, X. Zhang, and X. Zhang Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in China Public Health 123 2009 540 544
2. M.M. Jamal, E.J. Yoon, and K.J. Vega Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans World J Gastroenterol 15 2009 5274 5278
3. V. Donadon, M. Balbi, and M. Ghersetti Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease World J Gastroenterol 15 2009 2506 2511
4. G. Chodick, A.D. Heymann, and L. Rosenmann Diabetes and risk of incident cancer: a large population-based cohort study in Israel Cancer Causes Control 21 2010 879 887
5. Y.C. Huang, J.K. Lin, and W.S. Chen Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease J Cancer Res Clin Oncol 137 2011 211 220
6. E.E. Calle, T.K. Murphy, and C. Rodriguez Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults Cancer Causes Control 9 1998 403 410 (Pubitemid 28466692)
7. S.S. Coughlin, E.E. Calle, and L.R. Teras Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults Am J Epidemiol 159 2004 1160 1167 (Pubitemid 38747263)
8. B.B. Barone, H.C. Yeh, and C.F. Snyder Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis JAMA 300 2008 2754 2764
9. C.J. Currie, C.D. Poole, and E.A. Gale The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 2009 1766 1777
10. S.L. Bowker, S.R. Majumdar, P. Veugelers, and J.A. Johnson Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 2006 254 258 (Pubitemid 44106500)
11. V. Donadon, M. Balbi, and P. Casarin Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin World J Gastroenterol 14 2008 5695 5700
12. J.L. Wright, and J.L. Stanford Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study Cancer Causes Control 20 2009 1617 1622
13. J.M. Evans, L.A. Donnelly, and A.M. Emslie-Smith Metformin and reduced risk of cancer in diabetic patients BMJ 330 2005 1304 1305 (Pubitemid 40813563)
14. A.A. Samani, S. Yakar, and D. LeRoith The role of the IGF system in cancer growth and metastasis: overview and recent insights Endocr Rev 28 2007 20 47 (Pubitemid 46220849)
15. E. Giovannucci, D.M. Harlan, and M.C. Archer Diabetes and cancer: a consensus report Diabetes Care 33 2010 1674 1685
16. G. Libby, L.A. Donnelly, and P.T. Donnan New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes Diabetes Care 32 2009 1620 1625
17. U. Smith, and E.A. Gale Does diabetes therapy influence the risk of cancer? Diabetologia 52 2009 1699 1708
18. L.G. Hemkens, U. Grouven, and R. Bender Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 2009 1732 1744
19. J.M. Jonasson, R. Ljung, and M. Talbäck Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden Diabetologia 52 2009 1745 1754
20. H.M. Colhoun SDRN Epidemiology Group Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 2009 1755 1765
21. J. Rosenstock, V. Fonseca, and J.B. McGill Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study Diabetologia 52 2009 1971 1973
22. M. Barchana, I. Liphshitz, and P. Rozen Trends in colorectal cancer incidence and mortality in the Israeli Jewish ethnic populations Familial Cancer 3 2004 207 214 (Pubitemid 39491736)
23. Israel Ministry of Health Publication 310: cancer in Israel, trends in incidence and mortality http://www.health.gov.il/Download/pages/cancer290109.pdf
24. A. Heymann, G. Chodick, H. Halkin, E. Kokia, and V. Shalev Description of a diabetes disease register extracted from a central database Harefuah 146 2007 15 79
25. M.S. McFarland, and R. Cripps Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs Pharmacotherapy 30 2010 1159 1178
26. D.M. Baur, J. Klotsche, O.P. Hamnvik, C. Sievers, and L. Pieper Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort Metabolism 2010 [Epub ahead of print]
27. B.B. Duncan, and M.I. Schmidt Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research Diabetes Care 32 2009 1748 1750
28. E. Giovannucci, and D. Michaud The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas Gastroenterology 132 2007 2208 2225 (Pubitemid 46693749)
29. K.T. Khaw, N. Wareham, S. Bingham, and R. Luben Preliminary communication: glycated hemoglobin, diabetes and incidental colorectal cancer in man and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study Cancer Epidemiol Biomarkers Prev 13 2004 915 919 (Pubitemid 38756700)
30. E.A. Platz, S.E. Hankinson, N. Rifai, and G.A. Colditz Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States) Cancer Causes Control 10 1999 379 386 (Pubitemid 29454314)
31. S.T. Hawley, S.W. Vernon, and B. Levin Prevalence of colorectal cancer screening in a large medical organization Cancer Epidemiol Biomarkers Prev 13 2004 314 319 (Pubitemid 38222566)
32. B. Rosen, A. Porath, L.G. Pawlson, and M.R. Chassin Adherence to standards of care by health maintenance organizations in Israel and the USA Int J Qual Health Care 23 2011 15 25